ATE190487T1 - Granuläre zubereitung - Google Patents

Granuläre zubereitung

Info

Publication number
ATE190487T1
ATE190487T1 AT93923650T AT93923650T ATE190487T1 AT E190487 T1 ATE190487 T1 AT E190487T1 AT 93923650 T AT93923650 T AT 93923650T AT 93923650 T AT93923650 T AT 93923650T AT E190487 T1 ATE190487 T1 AT E190487T1
Authority
AT
Austria
Prior art keywords
administration
pharmaceutical preparation
preparation
granular pharmaceutical
tube
Prior art date
Application number
AT93923650T
Other languages
English (en)
Inventor
Hiroaki Nakagami
Taketoshi Keshikawa
Original Assignee
Daiichi Seiyaku Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Seiyaku Co filed Critical Daiichi Seiyaku Co
Priority claimed from PCT/JP1993/001553 external-priority patent/WO1995011674A1/ja
Application granted granted Critical
Publication of ATE190487T1 publication Critical patent/ATE190487T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1652Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1617Organic compounds, e.g. phospholipids, fats
    • A61K9/1623Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1635Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
AT93923650T 1993-10-27 1993-10-27 Granuläre zubereitung ATE190487T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/JP1993/001553 WO1995011674A1 (fr) 1992-04-28 1993-10-27 Preparation granulaire

Publications (1)

Publication Number Publication Date
ATE190487T1 true ATE190487T1 (de) 2000-04-15

Family

ID=14070606

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93923650T ATE190487T1 (de) 1993-10-27 1993-10-27 Granuläre zubereitung

Country Status (6)

Country Link
US (1) US6335036B1 (de)
AT (1) ATE190487T1 (de)
DE (1) DE69328128T2 (de)
DK (1) DK0729756T3 (de)
ES (1) ES2145065T3 (de)
RU (1) RU2143898C1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2368484A1 (en) 1999-03-31 2000-10-05 Daiichi Pharmaceutical Co., Ltd. Substrates for thioredoxin reductase
US20050191357A1 (en) * 2002-03-20 2005-09-01 Yoshiaki Kawashima Method of manufacturing chemical-containing composite particles
RU2491066C2 (ru) * 2008-02-28 2013-08-27 Сантен Фармасьютикал Ко., Лтд. Средство для профилактики и лечения глазного заболевания, сопровождающегося нарушением деятельности зрительного нерва
US10058542B1 (en) 2014-09-12 2018-08-28 Thioredoxin Systems Ab Composition comprising selenazol or thiazolone derivatives and silver and method of treatment therewith
WO2023240092A1 (en) * 2022-06-06 2023-12-14 Sound Pharmaceuticals Inc. Ebselen containing oral dosage forms

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3027073C2 (de) * 1980-07-17 1985-03-07 A. Nattermann & Cie GmbH, 5000 Köln Pharmazeutische Präparate, enthaltend 2-Phenyl-1,2-benzisoselenazol-3(2H)-on
DE3027075A1 (de) 1980-07-17 1982-02-18 A. Nattermann & Cie GmbH, 5000 Köln Benzisoselenazolone, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate
DK150008C (da) * 1981-11-20 1987-05-25 Benzon As Alfred Fremgangsmaade til fremstilling af et farmaceutisk oralt polydepotpraeparat
DE3226284A1 (de) 1982-07-14 1984-01-19 A. Nattermann & Cie GmbH, 5000 Köln Neue benzisoselenazolone, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate
JPS5942313A (ja) * 1982-09-01 1984-03-08 Teijin Ltd ポリビニルポリピロリドンを用いた製剤
DE3407511A1 (de) 1984-03-01 1985-09-05 A. Nattermann & Cie GmbH, 5000 Köln Benzisoselenazolthione, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate
DE3616923A1 (de) 1986-05-20 1987-11-26 Nattermann A & Cie Neue pharmazeutische verwendung von 2-phenyl-1,2-benzisoselenazol-3(2h)-on
DE3620674A1 (de) * 1986-06-20 1987-12-23 Nattermann A & Cie Salbe zur behandlung von hauterkrankungen
JPH0755905B2 (ja) 1986-07-17 1995-06-14 第一製薬株式会社 肝臓疾患治療剤
US4778814A (en) * 1987-03-18 1988-10-18 Ciba-Geigy Corporation Method of treating ocular allergy by topical application of a 2-substituted-1,2-benzisoselenazol-3(2H)-one
DE3720493A1 (de) * 1987-06-20 1989-01-26 Nattermann A & Cie Arzneizubereitungen mit mikronisierten ebselen-kristallen
JPS6413522A (en) 1987-07-08 1989-01-18 Ricoh Kk Liquid crystal display device
DE3821392A1 (de) 1988-06-24 1989-12-28 Nattermann A & Cie Neue pharmazeutische verwendung von 2-phenyl-1,2-benzisoselenazol-3(2h)-on (ebselen)
DE3827093A1 (de) * 1988-08-10 1990-02-15 Nattermann A & Cie Verfahren zur herstellung von hochreinem ebselen
US5288734A (en) * 1988-10-29 1994-02-22 A. Nattermann & Cie Gmbh Stable parenteral solution of 2-phenyl-1.2-benzisoselenazol-3(2H)-one and process for producing the same
US5385726A (en) * 1990-08-06 1995-01-31 Rhone-Poulenc Rorer Gmbh Use of 2-phenyl-1,2-benzisoselenazol-3-(2H)-one
DE4024885C2 (de) 1990-08-06 2002-07-18 Nattermann A & Cie Verwendung von 2-Phenyl-1,2-benzisoselenazol-3(2H)-on
EP0826370B1 (de) * 1996-08-27 2002-06-19 A. Nattermann & Cie. GmbH Pharmazeutische Zubereitung, die 2-Phenyl-1,2-Benzoisoelenazol-3(2H)-one enthält, für die Behandlung der Alzheimer-Krankheit

Also Published As

Publication number Publication date
US6335036B1 (en) 2002-01-01
DE69328128D1 (de) 2000-04-20
DK0729756T3 (da) 2000-06-05
ES2145065T3 (es) 2000-07-01
RU2143898C1 (ru) 2000-01-10
DE69328128T2 (de) 2000-08-24

Similar Documents

Publication Publication Date Title
ATE99927T1 (de) Pharmazeutische formulierungen.
FI924247A (fi) En doseringsform foer frigoerande av medicin till tarmen
WO2002000193A3 (en) Multiple stimulus reversible hydrogels
NO924104L (no) Pulverformulering med flytekontrollert avgivelse
BR9008022A (pt) Amida de acido isoxazol-4-carboxilico e amidas de acido hidroxialquilideno-cianoacetico,medicamentos contendo estes compostos e sua aplicacao
ATE73650T1 (de) Arzneimittel, die hohle, feine, roehrchenfoermige wirkstoffabgabesysteme enthalten.
ES445014A1 (es) Procedimiento de obtencion de preparaciones farmaceuticas noamargas, para la administracion oral.
ATE198152T1 (de) Oral anzuwendende arzneizubereitung mit verzögerter wirkstoffabgabe
DE3860967D1 (de) Arzneimittel in form stabiler suspendiermittel freier sucralfat-suspensionen.
ATE190487T1 (de) Granuläre zubereitung
DE3367324D1 (en) Pharmaceutical products in sustained-release form, and their preparation process
DE69008107D1 (de) Zubereitung mit verzögerter Freigabe eines Hydrochlorids eines basischen Arzneistoffs.
EP0729756A4 (de) Granuläre zubereitung
KOMATSU et al. Biopharmaceutical evaluation of gelatin microcapsules of sulfonamides
KR870010082A (ko) 구아르(guar) 분말
RU96110213A (ru) Гранулированный фармацевтический препарат
ATE256134T1 (de) Sulfatierte phosphatidylinositole, ihre herstellung und verwendung
ATE169818T1 (de) Carbamazepin-arzneiform mit verzögerter wirkstofffreisetzung
GB1219026A (en) Tablet preparation
Rešić et al. Intravenous acetaminophen overdose: a case report of a therapeutic error
Nelson et al. Respite care for the severely disabled child.
TH26552A (th) วิธีการรักษา
Shidore et al. EFFECT OF AMMONIUM CHLORIDE AND SODIUM BICARBONATE ON PHARMACOIUNETICS OF THREE SULFONAMIDES
JPS6479111A (en) Sustained release preparation and production thereof
SE8505034D0 (sv) Kropp bestaende av en kerna med ett overdrag

Legal Events

Date Code Title Description
REN Ceased due to non-payment of the annual fee